Case report: Additional use of hydroxychloroquine in treatment-resistant recurrent cerebral infarctions with antiphospholipid antibody syndrome

Int J Rheum Dis. 2024 Feb;27(2):e15056. doi: 10.1111/1756-185X.15056.

Authors

Shuntaro Isogai^{1

2}, Masayuki Mizuno³, Koji Uehara^{1

2}, Kenji Okita³, Taio Naniwa^{1

2}

Affiliations

¹ Division of Rheumatology, Department of Internal Medicine, Nagoya City University Hospital, Nagoya, Aichi, Japan.
² Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
³ Department of Neurology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.

PMID: 38334164
DOI: 10.1111/1756-185X.15056

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Antiphospholipid
Antiphospholipid Syndrome* / complications
Antiphospholipid Syndrome* / diagnosis
Antiphospholipid Syndrome* / drug therapy
Cerebral Infarction / diagnostic imaging
Cerebral Infarction / drug therapy
Cerebral Infarction / etiology
Humans
Hydroxychloroquine / therapeutic use

Substances

Hydroxychloroquine
Antibodies, Antiphospholipid